EZH2 and carcinoma: Thus, the immunoexpression of EZH2 can be analyzed in Grade 1 carcinomas and can be followed immunohistochemically to see any conversion to higher grade, as Grade 1 shows low expression and Grade 3 shows higher expression of EZH2.